Compile Data Set for Download or QSAR
maximum 50k data
Found 132 of ic50 for UniProtKB: A0A024R1A3
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329794((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(1-naphth...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329795((rac)((1R,2R,3S,4R)-4-(2-(biphenyl-3-yl)pyrazolo[1...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329797((rac)-((1R,2R,3S,4R)-4-((2-(3-Chlorophenyl)pyrazol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329799((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(3-(trifl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329802((rac)-((1R,2R,3S,4R)-4-(2-(dibenzo[b,d]furan-4-yl)...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329807((rac)-((1R,2R,3S,4R)-4-((2-(3-(tert-Butyl)phenyl)p...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329808((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(naphthale...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329809((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(quinolin...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329810((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(isoquinol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329811((rac)-((1R,2R,3S,4R)-4-(2-(dibenzo[b,d]furan-2-yl)...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329812((rac)-((1R,2R,3S,4R)-4-(2-(5-chloro-2-methoxypheny...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329813((rac)-((1R,2R,3S,4R)-4-(2-(5-chloro-2-methylphenyl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329814((rac)-((1R,2R,3S,4R)-4-(2-(benzo[b]thiophen-3-yl)p...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329816((rac)-((1R,2R,3S,4R)-4-(2-(1H-indol-2-yl)pyrazolo[...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329818((rac)-((1R,2R,3S,4R)-4-(2-(3,3-dimethyl-2,3-dihydr...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329819((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(isoquinol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329820((rac)-((1R,2R,3S,4R)-4-((2-(3-Bromophenyl)pyrazolo...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329821((rac)-((1R,2R,3S,4R)-4-((2-(2-Fluoro-5-(trifluorom...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329822((rac)-((1R,2R,3S,4R)-4-((2-(2-Chloro-5-(trifluorom...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329823((rac)-[(1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(4-phenyl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329824((rac)-[(1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(1H-indol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329825((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(5-(triflu...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329826((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(quinolin-...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329827((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(trimet...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329828((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(3-(pyrid...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329829((rac)-[(1R,2R,3S,4R)-4-{[2-(9H-carbazol-3-yl)pyraz...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329830((rac)-[(1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(5-methyl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329831((rac)-((1R,2R,3S,4R)-4-(2-(7-chloroquinolin-4-yl)p...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329832((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(3-(trifl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329833((rac)-((1R,2R,3S,4R)-4-(2-(3,3-dimethyl-2,3-dihydr...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329834((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(quinolin-...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329835((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(quinolin-...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329836((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(triflu...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329837((rac)-((1R,2R,3S,4R)-4-((2-(Benzo[b]thiophen-7-yl)...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329838((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(pyrrol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329839((rac)-(1R,2R,3S,4R)-4-(2-(3-cyclopentenylphenyl)py...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329840((rac)-[(1R,2R,3S,4R)-4-{[2-(3-cyclopentylphenyl)py...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329841((rac)-((1R,2R,3S,4R)-4-(2-(benzofuran-3-yl)pyrazol...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329842((rac)-((1R,2R,3S,4R)-4-((2-(3-(Difluoromethoxy)phe...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329844((rac)-((1R,2R,3S,4R)-4-(2-(6-tert-butylpyridin-2-y...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329845((rac)-((1R,2R,3S,4R)-4-(2-(3,3-dimethyl-1,3-dihydr...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329846((rac)-[(1R,2R,3S,4R)-4-{[2-(5-chloro-1H-indol-3-yl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329847((rac)-[(1R,2R,3S,4R)-4-{[2-(6-chloro-1H-indol-3-yl...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329848((rac)-((1R,2R,3S,4R)-4-((2-(Dibenzo[b,d]thiophen-4...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329849((rac)-((1R,2R,3S,4R)-4-(2-(5-chloro-2-(trifluorome...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329850((rac)-((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(1,1,1-...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329853((rac)-((1R,2R,3S,4R)-4-((2-(Benzo[b]thiophen-4-yl)...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329854((rac)-[(1R,2R,3S,4R)-4-{[2-(9H-carbazol-2-yl)pyraz...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM347108(US10202389, Compound I-063 | US10202389, Example 9...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme 1(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM329857((rac)-((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(2-methox...)
Affinity DataIC50: <10nMAssay Description:The UAE enzymatic reaction totals 50 μL and contains 50 mmol HEPES (pH 7.5), 0.05% BSA, 2.5 mM MgCl2, 0.1 uM ATP, 8 nM GST-Ubc-2, 35 nM flag-ubi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 132 total ) | Next | Last >>
Jump to: